BDBM50334037 (2-(3-(morpholinomethyl)phenyl)-4-(3-(trifluoromethyl)phenyl)-1H-imidazol-1-yl)(phenyl)methanone::CHEMBL1644673

SMILES FC(F)(F)c1cccc(c1)-c1cn(C(=O)c2ccccc2)c(n1)-c1cccc(CN2CCOCC2)c1

InChI Key InChIKey=QHTOQMQRWXVJSG-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50334037   

TargetCannabinoid receptor 2(Human)
Merck Research Laboratory

Curated by ChEMBL
LigandPNGBDBM50334037((2-(3-(morpholinomethyl)phenyl)-4-(3-(trifluoromet...)
Affinity DataEC50:  11nMAssay Description:Agonist activity at human cloned CB2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP accumulationMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/22/2011
Entry Details Article
PubMed